Natural Alternatives Inte... (NAII)
undefined
undefined%
At close: undefined
4.30
0.00%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally.

The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing.

It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.

The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review.

In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names.

The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders.

Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.

Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Natural Alternatives International Inc.
Natural Alternatives International Inc. logo
Country United States
IPO Date Oct 28, 1993
Industry Packaged Foods
Sector Consumer Defensive
Employees 296
CEO Mark A. LeDoux J.D.

Contact Details

Address:
1535 Faraday Avenue
Carlsbad, California
United States
Website https://www.nai-online.com

Stock Details

Ticker Symbol NAII
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000787253
CUSIP Number 638842302
ISIN Number US6388423021
Employer ID 84-1007839
SIC Code 2833

Key Executives

Name Position
Mark A. LeDoux J.D. Chairman of the Board & Chief Executive Officer
Shane Conti Vice President of Global Sales

Latest SEC Filings

Date Type Title
Dec 10, 2024 8-K Current Report
Nov 13, 2024 10-Q Quarterly Report
Nov 13, 2024 10-Q Quarterly Report
Oct 23, 2024 DEF 14A Filing
Sep 27, 2024 10-K Annual Report
May 14, 2024 10-Q Quarterly Report
Mar 15, 2024 4 Filing
Mar 15, 2024 4 Filing
Mar 15, 2024 4 Filing
Mar 11, 2024 4 Filing